GW Pharmaceuticals’ Epidiolex is the first FDA-approved cannabis-based drug.
With the legalization of cannabis in some U.S. states, the cannabis industry is projected to grow as much as $21 billion by 2020.
PotNetwork Holdings, Inc. (OTCMKTS:POTN) plans to expand and make its products available to underdeveloped sectors.
A recent study revealed that a significant drop in binge drinking ratings were observed among states which permit the use of recreational cannabis.
If the Hemp Farming Act of 2018 is approved by Congress, the hemp market could see the sales of related products reach up to $75 billion...
One report stated that the antidepressant market is forecasted to reach $7.3 billion by 2024.
Vapor Group, Inc. (OTC Pink: VPOR) had a stellar performance towards the end of 2017 and have taken steps to ensure that 2018 will be a...
In this year's markets, Bitcoin could collapse, oil prices will drop, electric cars will get a boost and many more.
With stiff competition from established medical companies and the stigma linked to marijuana, the challenges are real.
A handful of clinical studies have demonstrated the safety of using cannabis in cancer patients, but none have been able to transfer the cancer killing ability...